Business Context and Reporting Period
Company: Achieve Life Sciences, Inc. (ACHV)
Filing Type: Form 8-K (Current Report)
Date of Report: April 28, 2023
Reporting Period: Single event date (April 28, 2023)
This filing serves as a Regulation FD disclosure regarding an administrative update to the Company's principal executive offices.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report contains no financial performance data.
Material Changes
Change in Principal Executive Offices: Effective April 28, 2023, the Company updated its principal executive offices to include two locations:
- 1040 West Georgia, Suite 1030, Vancouver, B.C., Canada, V6E 4H1
- 22722 29th Drive SE, Suite 100, Bothell, WA 98021
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary on operations, risks, contingencies, or unusual items. The document is limited to the address change notification.
Key Facts for Investor Verification
- Verify the Company's current contact information and mailing addresses for official correspondence.
- Confirm that the dual-office structure (Vancouver, Canada and Bothell, Washington) reflects the Company's operational footprint.
- Note that this filing does not contain financial results or strategic updates; refer to 10-Q or 10-K filings for financial data.